Filter Results:
(353)
Show Results For
- All HBS Web
(353)
- People (2)
- News (142)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (70)
Show Results For
- All HBS Web
(353)
- People (2)
- News (142)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (70)
- 01 Mar 2018
- What Do You Think?
Two Decades Later, is the 'New Economy' Finally Here?
second of these books, Exponential Organizations (“ExOs”), explores the impact of new technologies on organizations. These are organizations driven by such things as AI, robotics, biotech and bioinformatics, data science, and 3D printing.... View Details
Keywords: by James Heskett
- 08 Jul 2021
- Blog Post
Managing Sustainable Advantage with Key ESG Co-Founders, Anne-Marie Schoonbeek and Heleen van Poecke
internship and then later back to McKinsey after graduation, where she focused on both large-cap and startups in the pharmaceuticals and biotech space. “For me, this was a way of making an impact,” said Schoonbeek. van Poecke began her... View Details
- Web
Bringing the Next Pandemic Vaccine to Your Doorstep with MIMIX - Blog: Health Supplement
next pandemic. As COVID taught us, the more we prepare now, the quicker we can get back to normal when the next pandemic hits. As I look back at Vaxess years, it has been fantastic to see life sciences grow at HBS and within the Boston View Details
- 04 Apr 2022
- Research & Ideas
Tech Hubs: How Software Brought Talent and Prosperity to New Cities
move to one of the big tech clusters like San Francisco,” Kerr says. “Likewise, if you are a biotech entrepreneur, there are enormous advantages to being in the Boston area. But there are also a lot of inventors who work in spaces that... View Details
Keywords: by Rachel Layne
- 26 Nov 2001
- Research & Ideas
Women Entrepreneurs Use Springboard for Funding
personalize healthcare and benefits, and Carol Nacy of Sequella, Inc., a biotech firm focused on controlling global infectious diseases, especially tuberculosis. Most of the companies were already up and running. Their funding to date has... View Details
Keywords: by Martha Lagace
- 06 Apr 2023
- Blog Post
Circularity in Denmark
Kalundborg Refinery’s second generation bioethanol production from wheat straw. We closed the day with an inspiring view of how this biotech hub will continue leading innovation in sustainable energy infrastructure as Kalundborg Utility... View Details
- 22 Feb 2022
- News
An Rx for Small Business Recovery
cluster concept pioneered by Michael Porter, the Bishop William Lawrence University Professor (Renewal Leave) at HBS, Mills argues that organizing a region’s small and large businesses around specialized industries—such as biotech in... View Details
Keywords: Deborah Blagg
- 01 Sep 2012
- News
High Honors
companies, primarily in the computer and health-care realm. In the four decades since, Johnson has helped build the biotech industry and earned a reputation as a thoughtful investor, trusted adviser, and generous philanthropist. Among his... View Details
- 10 May 2017
- Research & Ideas
Amazon Web Services Changed the Way VCs Fund Startups
cloud-based software and service companies, which could take advantage of AWS to decrease costs, versus others like biotechs that were less impacted by the new technologies. “The goal was to try and understand whether VCs were allocating... View Details
- 16 Feb 2004
- Research & Ideas
HBS Center Focuses on Europe
growth decisions facing Direvo, a young German biotech firm, when one of their partners suddenly wants to become an investor and the company expands both its customer and investor base in Europe and not just in Germany. Still a relatively... View Details
Keywords: by Cynthia Churchwell
- 01 Jun 2003
- News
Student Conferences, at a Glance
Jurvetson; Jeffrey C. Walker (MBA 1981), managing general partner, JPMorgan Partners; Stephen A. Schwarzman (MBA 1972), founding partner, president, & CEO, The Blackstone Group Fewer but better biotech companies are being funded with... View Details
- 10 Jun 2021
- Blog Post
Managing Sustainable Advantage with Key ESG Cofounders, Anne-Marie Schoonbeek and Heleen van Poecke
internship and then later back to McKinsey after graduation, where she focused on both large-cap and startups in the pharmaceuticals and biotech space. “For me, this was a way of making an impact,” said Schoonbeek. van Poecke began her... View Details
- 23 Oct 2018
- First Look
New Research and Ideas, October 23, 2018
case:https://hbsp.harvard.edu/product/318082-PDF-ENG Harvard Business School Case 318-083 Sandra Brown Goes Digital (B): The Commitment Decision Sandra Brown, a middle manager at a biotech company who has led internal and external... View Details
Keywords: Dina Gerdeman
- 01 Dec 2004
- News
The Future of Stem Cells
year for research on existing lines, even as other countries are investing many times that amount. Says Cynthia Fisher (MBA ’90), president and CEO of BioMed 20/20 Technologies, a biotech and medical information products firm, “The... View Details
Keywords: Garry Emmons
- 24 May 2011
- First Look
First Look: May 24
case:http://cb.hbsp.harvard.edu/cb/product/211086-PDF-ENG Innovation and Growth at Actelion Ltd Gary P. Pisano, Daniela Beyersdorfer, and Ruth DittrichHarvard Business School Case 611-065 : In late 2010, Jean-Paul Clozel, CEO of the Swiss View Details
Keywords: Sean Silverthorne
- 19 Mar 2006
- Research & Ideas
Unlocking Your Investment Capital
Neither an asset's cost nor its size specifies its riskiness. For example, consider two assets, $1 billion of a single-drug biotech stock and $1 billion of U.S. Treasury bonds: Each has the same cost and size but they have radically... View Details
- 12 Sep 2006
- First Look
First Look: September 12, 2006
organization's relational capacity. The benefits will reverberate throughout every dimension of the company's work. Financial Contracting in Biotech Strategic Alliances Authors:David T. Robinson and Toby E. Stuart Periodical:Journal of... View Details
Keywords: Sean Silverthorne
- 01 Sep 2008
- News
Mara Aspinall
ASPINALL Illustration by Jack Unruh When you ask people about their great fears in life, virtually everyone talks about cancer,” says Mara G. Aspinall (MBA ’87), past president of Genzyme Genetics, a Westborough, Massachusetts-based division of the View Details
- 20 Jul 2015
- Research & Ideas
Globalization Hasn’t Killed the Manufacturing Cluster
the federal government to create new clusters in the United States. He points to the rise of biotech in Harvard's backyard, which began despite government opposition in the 1970s. Clusters "tend to emerge much more organically, and they... View Details
- 06 Feb 2007
- First Look
First Look: February 6, 2007
Harvard Business School Supplement 107-049 Supplements the (A) case. Purchase this supplement: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=107049 Monsanto: Realizing Biotech Value in Brazil Harvard Business School Case... View Details
Keywords: Martha Lagace